The measurement of cardiac markers: where should we focus?

Mauro Panteghini1

  • 1Clinical Chemistry Laboratory, Azienda Ospedaliera Spedali Civili, Bresica, Italy.

Insights

Cardiac markers are crucial for managing acute chest pain and acute coronary syndrome. This review covers biomarker selection, interpretation, and key issues for effective laboratory use.

Area of Science:

  • Clinical Chemistry
  • Cardiology
  • Laboratory Medicine

Background:

  • Cardiac markers are central to current medical discussions.
  • They are vital for cost-effective acute chest pain and acute coronary syndrome management.

Purpose of the Study:

  • To review evidence-based knowledge on cardiac biomarker utilization.
  • To summarize analytic and clinical issues in biomarker determination.
  • To reference expert group recommendations.

Main Methods:

  • Literature review of cardiac biomarker studies.
  • Analysis of recommendations from laboratory medicine and cardiology groups.
  • Synthesis of information on test selection and interpretation.

Main Results:

  • Cardiac markers play a significant role in diagnosing acute conditions.
  • Proper selection and interpretation by the laboratory are critical.
  • Understanding sources of variation is key for accurate results.

Conclusions:

  • Evidence-based knowledge is essential for optimal cardiac marker testing.
  • The laboratory's role is pivotal in guiding the use of these biomarkers.
  • Adherence to expert recommendations ensures effective clinical application.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...